Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer. (Q47292033)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

7

Mototsugu Oya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

3

Nobuyuki Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Kazuyuki Yuge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Akira Miyajima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Suguru Shirotake

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Takeo Kosaka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

8 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

3987-3993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872290%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

The renin-angiotensin system and cancer: old dog, new tricks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Management of stage T1 tumors of the bladder: International Consensus Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z

A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2568-Z